Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 69
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Nat Med ; 4(8): 923-8, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9701244

RESUMEN

Acquisition of invasive/metastatic potential through protease expression is an essential event in tumor progression. High levels of components of the plasminogen activation system, including urokinase, but paradoxically also its inhibitor, plasminogen activator inhibitor 1 (PAI1), have been correlated with a poor prognosis for some cancers. We report here that deficient PAI1 expression in host mice prevented local invasion and tumor vascularization of transplanted malignant keratinocytes. When this PAI1 deficiency was circumvented by intravenous injection of a replication-defective adenoviral vector expressing human PAI1, invasion and associated angiogenesis were restored. This experimental evidence demonstrates that host-produced PAI is essential for cancer cell invasion and angiogenesis.


Asunto(s)
Invasividad Neoplásica/prevención & control , Neovascularización Patológica/prevención & control , Inhibidor 1 de Activador Plasminogénico/biosíntesis , Inhibidor 1 de Activador Plasminogénico/deficiencia , Neoplasias Cutáneas/patología , Adenoviridae , Animales , Transformación Celular Neoplásica , Células Cultivadas , Progresión de la Enfermedad , Femenino , Vectores Genéticos , Genotipo , Humanos , Queratinocitos/patología , Masculino , Mesodermo/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Metástasis de la Neoplasia , Inhibidor 1 de Activador Plasminogénico/genética , Neoplasias Cutáneas/irrigación sanguínea , Transfección
2.
J Cell Biol ; 152(4): 777-84, 2001 Feb 19.
Artículo en Inglés | MEDLINE | ID: mdl-11266468

RESUMEN

The plasminogen (Plg)/plasminogen activator (PA) system plays a key role in cancer progression, presumably via mediating extracellular matrix degradation and tumor cell migration. Consequently, urokinase-type PA (uPA)/plasmin antagonists are currently being developed for suppression of tumor growth and angiogenesis. Paradoxically, however, high levels of PA inhibitor 1 (PAI-1) are predictive of a poor prognosis for survival of patients with cancer. We demonstrated previously that PAI-1 promoted tumor angiogenesis, but by an unresolved mechanism. We anticipated that PAI-1 facilitated endothelial cell migration via its known interaction with vitronectin (VN) and integrins. However, using adenoviral gene transfer of PAI-1 mutants, we observed that PAI-1 promoted tumor angiogenesis, not by interacting with VN, but rather by inhibiting proteolytic activity, suggesting that excessive plasmin proteolysis prevents assembly of tumor vessels. Single deficiency of uPA, tissue-type PA (tPA), uPA receptor, or VN, as well as combined deficiencies of uPA and tPA did not impair tumor angiogenesis, whereas lack of Plg reduced it. Overall, these data indicate that plasmin proteolysis, even though essential, must be tightly controlled during tumor angiogenesis, probably to allow vessel stabilization and maturation. These data provide insights into the clinical paradox whereby PAI-1 promotes tumor progression and warrant against the uncontrolled use of uPA/plasmin antagonists as tumor angiogenesis inhibitors.


Asunto(s)
Inhibidores de la Angiogénesis/farmacología , Endopeptidasas/metabolismo , Neoplasias Experimentales/tratamiento farmacológico , Neovascularización Patológica/tratamiento farmacológico , Inhibidor 1 de Activador Plasminogénico/farmacología , Vitronectina/metabolismo , Animales , Endotelio Vascular/efectos de los fármacos , Fibrinolisina/metabolismo , Queratinocitos/patología , Ratones , Ratones Mutantes , Neoplasias de los Músculos/irrigación sanguínea , Invasividad Neoplásica , Neoplasias Experimentales/irrigación sanguínea , Neovascularización Patológica/etiología , Inhibidor 1 de Activador Plasminogénico/metabolismo , Unión Proteica , Vitronectina/genética
3.
Science ; 153(3738): 870-1, 1966 Aug 19.
Artículo en Inglés | MEDLINE | ID: mdl-5914750

RESUMEN

Estimates of the water budget of Long Island Sound suggest that it could become the largest reservoir in the United States, with a freshwater surplus equal to 12 times the present needs of New York City. The engineering aspects of this undertaking are within the scope of present technology. The dam structures required to isolate this area from the sea could serve as important highway links in place of highway-bridge projects presently under study.


Asunto(s)
Abastecimiento de Agua , New York
4.
Science ; 203(4383): 894-7, 1979 Mar 02.
Artículo en Inglés | MEDLINE | ID: mdl-17771725

RESUMEN

Highly turbid bottom water at the margin of the Sohm Abyssal Plain was identified by its temperature, salinity, and oxygen content as originating upslope on the continental rise. The fact that the particulate concentrations were one to two orders of magnitude higher than are normally found in deep ocean waters suggests a turbidity current as the agent bringing this water downslope.

5.
Science ; 157(3794): 1300-2, 1967 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-17737437

RESUMEN

A method is proposed whereby potable water may be obtained by condensing moisture from the atmosphere in suitable seashore or island areas. Deep, cold, offshore seawater is used as a source of cold and is pumped to condensers set up on shore to intercept the flow of highly humid, tropical, maritime air masses. This air, when cooled, condenses moisture, which is conducted away and stored for use as a water supply. Windmill-driven generators would supply low-cost power for the operation. Side benefits are derived by using the nutritious deep water to support aquiculture in nearby lagoons or to enhance the productivity of the outfall area. Additional benefits are derived from the condenser as an air-conditioning device for nearby residents. The islands of the Caribbean are used as an example of a location in the trade-winds belt where nearly optimum conditions for the operation of this system can be found.

6.
J Clin Invest ; 98(10): 2364-72, 1996 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-8941655

RESUMEN

Endothelin-1 (ET-1) has been implicated in the regulation of vascular tone in various pathological conditions. To examine the effect of in vivo overexpression of the peptide in rats, we prepared recombinant adenovirus stocks encoding the human preproET-1 cDNA (Ad.ET-1) or Escherichia coli lacZ (Ad.betaGal), each driven by cytomegalovirus early promoter. Ad.ET-1 or Ad.betaGal was injected into the caudal vein of rats and the animals were studied under anesthesia 96 h later. Hepatic overexpression of the virus-derived human ET-1 mRNA was accompanied by a 13-fold elevation of liver ET-1 content in the Ad.ET-1 group. Circulating plasma ET-1 levels in the Ad.ET-1 group were sixfold higher than those in the Ad.betaGal group. Mean arterial blood pressure was increased by 28 mmHg in the Ad.ET-1 group as compared with the Ad.betaGal group. In the Ad.ET-1 group, intravenous infusion of the ET(A) receptor antagonist FR 139317 reduced the blood pressure to levels seen in the Ad.betaGal group, whereas the same antagonist did not significantly alter the blood pressure in the Ad.betaGal group. Intravenous infusion of the ET(B) receptor antagonist BQ-788 caused a small but significant increase in blood pressure in both groups. These findings demonstrate that endogenous overexpression of preproET-1, accompanied by an elevation of plasma ET-1 concentrations to the levels seen in pathophysiological states, can cause systemic hypertension through the activation of the ETA receptor.


Asunto(s)
Endotelina-1/genética , Endotelina-1/fisiología , Regulación de la Expresión Génica , Hipertensión/genética , Hipertensión/metabolismo , Adenovirus Humanos/genética , Animales , Azepinas/farmacología , Presión Sanguínea/genética , Northern Blotting , Citomegalovirus/genética , ADN Complementario/genética , Endotelina-1/antagonistas & inhibidores , Endotelina-1/sangre , Escherichia coli/genética , Vectores Genéticos , Humanos , Indoles/farmacología , Riñón/fisiología , Operón Lac , Hígado/metabolismo , Hígado/fisiología , Masculino , Oligopéptidos/farmacología , Piperidinas/farmacología , Regiones Promotoras Genéticas , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Recombinación Genética
7.
J Clin Invest ; 92(2): 883-93, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8349823

RESUMEN

We employed homologous recombination in embryonic stem cells to produce mice lacking functional LDL receptor genes. Homozygous male and female mice lacking LDL receptors (LDLR-/- mice) were viable and fertile. Total plasma cholesterol levels were twofold higher than those of wild-type litter-mates, owing to a seven- to ninefold increase in intermediate density lipoproteins (IDL) and LDL without a significant change in HDL. Plasma triglyceride levels were normal. The half-lives for intravenously administered 125I-VLDL and 125I-LDL were prolonged by 30-fold and 2.5-fold, respectively, but the clearance of 125I-HDL was normal in the LDLR-/- mice. Unlike wild-type mice, LDLR-/- mice responded to moderate amounts of dietary cholesterol (0.2% cholesterol/10% coconut oil) with a major increase in the cholesterol content of IDL and LDL particles. The elevated IDL/LDL level of LDLR-/- mice was reduced to normal 4 d after the intravenous injection of a recombinant replication-defective adenovirus encoding the human LDL receptor driven by the cytomegalovirus promoter. The virus restored expression of LDL receptor protein in the liver and increased the clearance of 125I-VLDL. We conclude that the LDL receptor is responsible in part for the low levels of VLDL, IDL, and LDL in wild-type mice and that adenovirus-encoded LDL receptors can acutely reverse the hypercholesterolemic effects of LDL receptor deficiency.


Asunto(s)
Terapia Genética , Hipercolesterolemia/genética , Hipercolesterolemia/terapia , Receptores de LDL/genética , Alelos , Animales , Secuencia de Bases , Colesterol/sangre , Colesterol en la Dieta , Mapeo Cromosómico , Cruzamientos Genéticos , Embrión de Mamíferos , Femenino , Humanos , Hipercolesterolemia/metabolismo , Lipoproteínas/sangre , Lipoproteínas IDL , Lipoproteínas LDL/sangre , Lipoproteínas VLDL/sangre , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Oligodesoxirribonucleótidos , Receptores de LDL/análisis , Receptores de LDL/metabolismo , Recombinación Genética , Mapeo Restrictivo , Células Madre/metabolismo
8.
J Clin Invest ; 98(2): 317-24, 1996 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-8755640

RESUMEN

Nitric oxide (NO), a vasodilator involved in the regulation of pulmonary vascular tone, is synthesized by a family of enzymes, nitric oxide synthases (NOS). To investigate whether adenoviral-mediated overexpression of constitutive endothelial NOS (ceNOS) would attenuate hypoxic pulmonary vasoconstriction, we aerosolized 3 X 10(9) plaque forming units of a recombinant adenovirus containing the ceNOS gene (AdCMVceNOS) into rat lungs. Four days after infection, transgene expression was confirmed using immunoblot techniques. Diffuse ceNOS immunostaining was detected in alveoli and medium-sized and small pulmonary vessels of AdCMVceNOS-transduced lungs. AdCMVceNOS-transduction was associated with an 86% increase in [3H]arginine to [3H]citrulline conversion and a rise in pulmonary cGMP levels from 7 +/- 1 to 59 +/- 9 pmol/mg protein in lungs from AdCMVceNOS versus control rats, (P < 0.05). During acute hypoxia (FIO2 = 0.10) for 25 min, mean pulmonary artery pressure (PAP) increased significantly from 17 +/- 1 to 27 +/- 1 mmHg in rats aerosolized with saline (n = 4) and from 18 +/- 1 to 28 +/- 1 mmHg in rats given an adenoviral vector expressing a nuclear-targeted beta-galactosidase gene (AdCMV beta gal, n = 8). In contrast, in AdCMVceNOS-transduced rats (n = 8) the hypoxia-induced increase in PAP was significantly attenuated (18 +/- 1 to 23 +/- 2 mmHg). Systemic blood pressure was not affected by aerosol gene transfer. Thus, adenoviral-mediated ceNOS gene transfer to rat lungs increases ceNOS expression and activity, and reduces acute hypoxic pulmonary vasoconstriction. Aerosolized recombinant adenovirus overexpressing vasodilatory proteins can act as a selective pulmonary vasodilator and may hold promise as a future therapeutic strategy for pulmonary hypertension.


Asunto(s)
Endotelio Vascular/enzimología , Técnicas de Transferencia de Gen , Pulmón/fisiología , Óxido Nítrico Sintasa/biosíntesis , Circulación Pulmonar/fisiología , Vasoconstricción , Adenoviridae , Análisis de Varianza , Animales , Secuencia de Bases , Línea Celular , Citomegalovirus , Cartilla de ADN , Vectores Genéticos , Humanos , Hipoxia , Inmunohistoquímica , Cinética , Pulmón/irrigación sanguínea , Datos de Secuencia Molecular , Óxido Nítrico Sintasa/análisis , Óxido Nítrico Sintasa/genética , Reacción en Cadena de la Polimerasa , Ratas , Ratas Wistar , Mapeo Restrictivo
9.
Mol Cell Biol ; 5(11): 3231-40, 1985 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-3018509

RESUMEN

Transformed monkey cell lines (CMT and BMT) that inducible express simian virus 40 (SV40) T antigen from the metallothionein promoter have been isolated and characterized. Immunoprecipitation of pulse-labeled T antigen demonstrates a 5- to 12-fold increase in the rate of synthesis on addition of heavy-metal inducers to the culture medium. Radioimmunoassay of cell extracts indicates the accumulation of three- to fourfold more total T antigen after 2 days of induction by comparison with uninduced controls. A direct correlation was found between the level of T-antigen synthesis and the extent of SV40 DNA replication in inducible cells. Inducible BMT cells expressing a low basal level of T antigen were efficiently transformed by a vector carrying the neomycin resistance marker and an SV40 origin of replication. These vector sequences were maintained in an episomal form in most G418-resistant cell lines examined and persisted even in the absence of biochemical selection. Extensive rearrangements were observed only if the vector contained bacterial plasmid sequences. Expression of a protein product under the control of the SV40 late promoter in such vectors was increased after heavy-metal-dependent amplification of the template. These results demonstrate the ability of BMT cells to maintain a cloned eucaryotic gene in an amplifiable episomal state.


Asunto(s)
Replicación del ADN , Virus 40 de los Simios/genética , Animales , Antígenos Transformadores de Poliomavirus , Antígenos Virales de Tumores/genética , Línea Celular , Chlorocebus aethiops , Clonación Molecular , Enzimas de Restricción del ADN , ADN de Neoplasias/genética , Genes , Células HeLa , Humanos , Riñón , Metalotioneína/genética , Proteínas Oncogénicas Virales/genética , Plásmidos , Regiones Promotoras Genéticas , Transfección
10.
Mol Cell Biol ; 2(7): 782-8, 1982 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-6100912

RESUMEN

A short segment of simian virus 40 (SV40) chromatin on the late side of the origin of replication is hypersensitive to nuclease cleavage. The role of DNA sequence information in this nuclease-sensitive feature was examined by constructing deletion mutations in this region. Deletions were introduced into the inserted segment of in(Or)-1411 (a viable, partially duplicated variant of SV40), and nuclease sensitivity of the inserted segment was compared with that of the unaltered sequences in their normal location in the viral genome. Extended deletions (118 to 161 base pairs) essentially abolished nuclease sensitivity within the inserted segment. Shorter deletions (21 to 52 base pairs) at separate locations retained the nuclease-sensitive feature. In some short-deletion mutants nuclease susceptibility was substantially reduced. We conclude that more than one genetic element in this region contributes to the organization of the nuclease-sensitive feature and that the SV40 72-base repeat is not, in itself, sufficient signal for this feature.


Asunto(s)
Cromatina/ultraestructura , Virus 40 de los Simios/genética , Animales , Cromatina/metabolismo , Deleción Cromosómica , Replicación del ADN , Endodesoxirribonucleasas/metabolismo , Mutación
11.
Mol Cell Biol ; 5(1): 52-8, 1985 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2984555

RESUMEN

A nuclease-sensitive region forms in chromatin containing a 273-base-pair (bp) segment of simian virus 40 DNA encompassing the viral origin of replication and early and late promoters. We have saturated this region with short deletion mutations and compared the nuclease sensitivity of each mutated segment to that of an unaltered segment elsewhere in the partially duplicated mutant. Although no single DNA segment is required for the formation of a nuclease-sensitive region, a deletion mutation (dl45) which disrupted both exact copies of the 21-bp repeats substantially reduced nuclease sensitivity. Deletion mutations limited to only one copy of the 21-bp repeats had little, if any, effect. A mutant (dl135) lacking all copies of the 21- and 72-bp repeats, while retaining the origin of replication and the TATA box, did not exhibit a nuclease-sensitive region. Mutants which showed reduced nuclease sensitivity had this effect throughout the nuclease-sensitive region, not just at the site of the deletion, indicating that although multiple determinants must be responsible for the nuclease-sensitive chromatin structure they do not function with complete independence. Mutant dl9, which lacks the late portion of the 72-bp segment, showed reduced accessibility to BglI, even though the BglI site is 146 bp away from the site of the deletion.


Asunto(s)
Cromatina/ultraestructura , Virus 40 de los Simios/ultraestructura , Secuencia de Bases , ADN Viral/genética , Endonucleasas , Mutación , Secuencias Repetitivas de Ácidos Nucleicos , Virus 40 de los Simios/genética
12.
Structure ; 2(12): 1259-70, 1994 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-7704534

RESUMEN

BACKGROUND: Adenoviral infection begins with the binding of virion to the surface of host cells. Specific attachment is achieved through interactions between host-cell receptors and the adenovirus fiber protein and is mediated by the globular carboxy-terminal domain of the adenovirus fiber protein, termed the carboxy-terminal knob domain. RESULTS: The crystal structure of the carboxy-terminal knob domain of the adenovirus type 5 (Ad5) fiber protein has been determined at 1.7 A resolution. Each knob monomer forms an eight-stranded antiparallel beta-sandwich structure. In the crystal lattice, the knob monomers form closely interacting trimers which possess a deep surface depression centered around the three-fold molecular symmetry axis and three symmetry-related valleys. CONCLUSIONS: The amino acid residues lining the wall of the central surface depression and the three symmetry-related floors of the valleys are strictly conserved in the knob domains of Ad5 and adenovirus type 2 (Ad2) fiber proteins, which share the same cellular receptor. The beta-sandwich structure of the knob monomer demonstrates a unique folding topology which is different from that of other known antiparallel beta-sandwich structures. The large buried surface area and numerous polar interactions in the trimer indicate that this form of the knob protein is predominant in solution, suggesting a possible assembly pathway for the native fiber protein.


Asunto(s)
Proteínas de la Cápside , Cápside/química , Receptores Virales/metabolismo , Secuencia de Aminoácidos , Cápside/metabolismo , Gráficos por Computador , Cristalografía por Rayos X , Datos de Secuencia Molecular , Conformación Proteica , Alineación de Secuencia
13.
Biochim Biophys Acta ; 1037(1): 16-23, 1990 Jan 19.
Artículo en Inglés | MEDLINE | ID: mdl-2403813

RESUMEN

Expression of human recombinant plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli has led to crystallization of 'latent' PAI-1. Cleavage with restriction endonucleases of a cDNA clone encoding PAI-1 yielded an 1127 base pair fragment encoding residues 2-376 of the 379 amino acid serpin. Synthetic DNA linkers were ligated to the 5' and 3' ends of the subclone to add an initiation codon and restore the full coding sequence, and the resulting semisynthetic gene was incorporated into an expression plasmid, pPAIST-7, under the control of the E. coli trp promoter. Transformation of E. coli GE81 with pPAIST-7 led to expression of unglycosylated PAI-1. Lysates of expression cultures contained PAI-1 activity and PAI-1 protein with the predicted Mr. Unglycosylated PAI-1 from E. coli exhibited characteristic properties of authentic PAI-1: (1) it was recovered in both active and inactive (latent) forms; (2) its activity declined during incubation at 37 degrees C; (3) latent PAI-1 was activated by treatment with 4 M guanidine hydrochloride; (4) reactivated PAI-1 formed a detergent-stable complex with tissue plasminogen activator. Latent PAI-1 accounted for more than 85% of PAI-1 in cell lysates and was purified by ammonium sulfate fractionation, anion-exchange chromatography and hydrophobic interaction chromatography. The purified latent PAI-1 was crystallized.


Asunto(s)
Inactivadores Plasminogénicos/aislamiento & purificación , Aminoácidos/análisis , Cromatografía por Intercambio Iónico , Cristalografía , Escherichia coli , Expresión Génica , Humanos , Plásmidos , Proteínas Recombinantes , Relación Estructura-Actividad
14.
Mol Endocrinol ; 7(8): 1072-85, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8232306

RESUMEN

Expression of the surfactant protein-A (SP-A) gene is lung specific and is developmentally and hormonally regulated in fetal lung tissue. Cyclic AMP analogs and glucocorticoids stimulate transcriptional activity of the SP-A gene in fetal rabbit lung tissue in culture; an additive effect is observed when the agents are added in combination. To analyze the genomic regions that regulate SP-A promoter activity, fusion genes comprised of -1766, -991, -378, and -47 basepairs (bp) of DNA flanking the 5'-end of the SP-A gene, the transcription initiation site, and 20 bp of exon I linked to the human GH (hGH) structural gene were subcloned into a replication-defective human adenovirus vector and transfected into differentiated rat type II cells in primary culture. SP-A promoter activity was analyzed by RIA of hGH protein in the culture medium. In type II cells transfected with SP-A-1766:hGH and SP-A-991:hGH fusion genes, hGH production was induced 30- to 40-fold by (Bu)2AMP (Bt2cAMP; 1 mM). When type II cells were transfected with the SP-A-378:hGH fusion gene, basal levels of expression were reduced by more than 50%; however, Bt2cAMP caused an 11-fold increase in hGH production. In type II cells transfected with the SP-A-47:hGH fusion gene, basal levels of hGH production were essentially undetectable, and no stimulatory effect of Bt2cAMP was apparent. Cyclic AMP stimulation of expression of the SP-A-1766:hGH, SP-A-991:hGH, and SP-A-378:hGH fusion genes was limited to type II pneumonocytes in primary culture and was absent in two lung adenocarcinoma cell lines (NCl-H358 and A549), which do not express SP-A, and in cAMP-responsive adrenal Y1 cells. Mutations of a putative cAMP-responsive element (TGACCTCA) at -261 bp revealed its functional importance in mediating cAMP regulation of SP-A gene expression. Unexpectedly, dexamethasone (Dex; 10(-7) M) antagonized the stimulatory effect of Bt2cAMP on expression of SP-A:hGH fusion genes containing from -378 to -1766 bp of 5'-flanking DNA as well as that of a fusion gene construct containing -991 bp of 5'-flanking DNA, the first exon, the first intron, and 20 bp of the second exon (SP-A-991+670:hGH). The inhibitory effect of Dex was dose dependent, with half-maximal inhibition occurring at a Dex concentration of 8 x 10(-10) M. The inhibitory effect of Dex was prevented by the glucocorticoid receptor antagonist RU486.(ABSTRACT TRUNCATED AT 400 WORDS)


Asunto(s)
Dexametasona/farmacología , Proteolípidos/genética , Surfactantes Pulmonares/genética , Secuencias Reguladoras de Ácidos Nucleicos , Transcripción Genética , Adenocarcinoma , Adenoviridae , Neoplasias de la Corteza Suprarrenal , Animales , Secuencia de Bases , Bucladesina/farmacología , Línea Celular , AMP Cíclico/fisiología , Virus Defectuosos , Regulación de la Expresión Génica/efectos de los fármacos , Genes , Vectores Genéticos , Hormona del Crecimiento/genética , Humanos , Neoplasias Pulmonares , Ratones , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Especificidad de Órganos , Proteína A Asociada a Surfactante Pulmonar , Proteínas Asociadas a Surfactante Pulmonar , Conejos , Ratas , Proteínas Recombinantes de Fusión/biosíntesis , Transcripción Genética/efectos de los fármacos , Células Tumorales Cultivadas
15.
Trends Cardiovasc Med ; 3(5): 171-7, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-21244929

RESUMEN

The introduction of foreign genetic material into somatic cells in intact organisms is an important investigational technique that holds considerable promise as a therapeutic tool. Although successful gene transfer has been achieved by the use of both cell-mediated and direct techniques, most strategies have been limited either by constraints on the type, accessibility, and growth state of the target cell population, or by the low efficiency of genetic modification. Among the available vectors for somatic cell gene transfer, recombinant adenoviruses have several properties that make them particularly attractive for direct, in vivo introduction of foreign genes into adult animals and people. Simple techniques for the efficient generation and propagation of recombinant adenoviruses have been developed, and early studies employing recombinant adenoviral vectors demonstrate their potential for broad experimental and eventual clinical application. To exploit this potential properly, a number of important issues, including the efficiency of genetic modification of a targeted cell population, stability of foreign gene expression, effects of host immune response, and cell-type specific targeting of gene transfer, remain to be addressed.

16.
Hum Gene Ther ; 10(7): 1105-15, 1999 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-10340543

RESUMEN

Recombinant adenoviral (Ad) vectors represent an efficient gene transfer system for targeting the cardiovascular system. Phenotypic modulation of coronary vascular cells in vivo is, however, critically dependent on the efficacy of local delivery devices. Four local drug delivery catheters were tested for intracoronary gene transfer efficiency: the Infiltrator (INF, n = 10), the Crescendo (CRE, n = 10), the Infusasleeve (SLE, n = 8), and the Remedy balloon (channel balloon [CHA], n = 8). After balloon injury of the LAD, Ad vector containing the firefly luciferase cDNA (AdCMVluc, 1.5 x 10(10) plaque-forming units) was administered at the site of injury. On day 4, tissue samples from different regions in the heart and from the liver were assayed for luciferase activity to evaluate local and systemic gene transfer. INF, CRE, and SLE catheters showed higher transduction levels of the target LAD segment than did the CHA catheter (median luciferase activity = 4.2 x 10(6), 11 x 10(6), and 1.3 x 10(6) light units [LU]/vessel versus 0.09 x 10(6) LU/vessel, respectively, p < 0.05). Luciferase activity was occasionally observed in nontarget tissues (right and left ventricular free wall, distal LAD, and liver) and was not significantly different between groups. The viral circulatory half-life was similar for the four groups (<1 min). Gene transfer efficiency was positively correlated with the degree of injury for the intralumenal catheters (CRE, SLE, and CHA) but was independent of the vessel wall injury for the intramural INF. Local drug delivery catheters enable efficient vascular gene transfer in balloon-injured coronary arteries, a prerequisite for further development of intracoronary gene therapy for restenosis.


Asunto(s)
Adenoviridae/genética , Cateterismo , Enfermedad Coronaria/terapia , Técnicas de Transferencia de Gen , Administración Cutánea , Angioplastia de Balón , Animales , Vasos Coronarios/anatomía & histología , Vasos Coronarios/lesiones , Modelos Animales de Enfermedad , Sistemas de Liberación de Medicamentos , Terapia Genética , Vectores Genéticos/administración & dosificación , Luciferasas/metabolismo , Músculo Liso , Porcinos
17.
Hum Gene Ther ; 11(9): 1329-39, 2000 Jun 10.
Artículo en Inglés | MEDLINE | ID: mdl-10890742

RESUMEN

Local intracoronary delivery of recombinant adenoviruses expressing anti-migratory or anti-proliferative proteins including human constitutive endothelial nitric oxide synthase (NOS3), plasminogen activator inhibitor 1 (PAI-1), or herpesvirus thymidine kinase (TK) (combined with ganciclovir) was used to prevent neointimal formation in porcine coronary arteries. After balloon injury of the left anterior descending (LAD) coronary artery, animals received an intramural injection of adenovirus (1.5 X 10(9) PFU) carrying either the NOS3 cDNA (AdCMVNOS3, n = 12), the PAI-1 cDNA (AdCMVPAI-1, n = 12), the TK cDNA (AdMLPItk, n = 12), or no cDNA (AdpL+, n = 12). After 28 days, morphometric analysis was performed on coronary sections from all segments demonstrating injury. The internal elastic lamina (IEL) fracture length normalized to the IEL perimeter (initial injury) and the neointimal area normalized to the vessel area (response to injury) were used to generate linear regression lines and calculate an index of stenosis for the respective treatment groups. The response to injury was significantly smaller in AdCMVNOS3- and AdMLPItk-infected animals than in AdpL+-infected animals (slopes = 0.86 +/- 0.05 and 0.69 +/- 0.07 versus 1.11 +/- 0.06, p < 0.005 and p < 0.0001, respectively) but not in AdCMVPAI-1-infected animals (slope = 1.26 +/- 0.04, p = 0.04). No viral shedding was observed and there was no acute systemic toxicity after gene transfer. An increase in neutralizing antibody titers against Ad vectors was observed without any detectable response to the transgene products (NOS3, PAI-1). Local gene transfer of NOS3 and TK may hold promise as a safe and effective adjunctive treatment to reduce neointimal formation after percutaneous coronary intervention in humans.


Asunto(s)
Arteriopatías Oclusivas/terapia , Vasos Coronarios/lesiones , Terapia Genética , Óxido Nítrico Sintasa/genética , Inhibidor 1 de Activador Plasminogénico/genética , Timidina Quinasa/genética , Adenovirus Humanos/genética , Adenovirus Humanos/inmunología , Adenovirus Humanos/aislamiento & purificación , Angioplastia Coronaria con Balón/efectos adversos , Animales , Anticuerpos Antivirales/análisis , Arteriopatías Oclusivas/patología , Vasos Coronarios/patología , Elastina/análisis , Técnicas de Transferencia de Gen , Vectores Genéticos/genética , Vectores Genéticos/inmunología , Herpesvirus Humano 1/enzimología , Óxido Nítrico Sintasa/inmunología , Óxido Nítrico Sintasa de Tipo III , Inhibidor 1 de Activador Plasminogénico/inmunología , Porcinos , Timidina Quinasa/inmunología
18.
J Mol Endocrinol ; 27(3): 321-8, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11719284

RESUMEN

The androgen receptor (AR) and closely related members of the steroid receptor family have proven difficult to obtain in native form in large quantities. In the case of the human AR (hAR), high-level expression in prokaryotic or non-mammalian cells leads to the synthesis of a high proportion of non-binding, insoluble, or degraded forms of the receptor protein. To circumvent these difficulties, we have constructed a recombinant adenovirus that directs the expression of hAR under the control of a potent, constitutive promoter. Infection of eukaryotic cells with this recombinant virus leads to the synthesis of large quantities of the intact AR. In contrast to expression methods designed to direct the full-length AR in bacteria, yeast, and insect cells, AR expressed in mammalian cells using this adenoviral vector accumulates at high levels, retains many properties of the native AR, and is not rapidly proteolyzed. This method will prove useful for large-scale preparations of hAR for use in functional and structural studies.


Asunto(s)
Receptores Androgénicos/genética , Receptores Androgénicos/metabolismo , Adenoviridae/genética , Animales , Línea Celular , Dihidrotestosterona/metabolismo , Estradiol/metabolismo , Expresión Génica , Genes Reporteros , Vectores Genéticos , Humanos , Hidrocortisona/metabolismo , Ligandos , Luciferasas/genética , Nandrolona/análogos & derivados , Nandrolona/metabolismo , Progesterona/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Solubilidad
19.
Am J Med ; 96(6): 492-6, 1994 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8017445

RESUMEN

PURPOSE: As cocaine abuse has become widespread, catastrophic cocaine-associated cardiovascular events have been noted with increasing frequency. Although these incidents are thought to be caused by drug-induced vasoconstriction and/or arterial thrombosis, the influence of cocaine on the plasma constituents involved in endogenous thrombosis and thrombolysis has not been characterized. PATIENTS AND METHODS: In 22 patients (8 men, 14 women, ages 32 to 62 years) undergoing cardiac catheterization, blood samples were procured before and 15 minutes after the administration of intranasal saline (n = 8, controls) or cocaine, 2 mg/kg (n = 14), and the plasma concentrations of fibrinogen, plasminogen, and lipoprotein(a), as well as tissue plasminogen activator activity and plasminogen activator inhibitor (PAI-1) activity, were measured. RESULTS: No variable changed with the use of intranasal saline, whereas the use of cocaine resulted in an increase in PAI-1 activity (0.48 + 0.06 [mean + SD] nmol/L at baseline, 0.53 + 0.05 nmol/L after cocaine, P = 0.011). CONCLUSION: Intranasal cocaine administration is associated with an increase in plasma PAI-1 activity. This may be important in recreational users of cocaine who experience vascular thrombosis.


Asunto(s)
Factores de Coagulación Sanguínea/metabolismo , Coagulación Sanguínea/efectos de los fármacos , Cocaína/farmacología , Administración Intranasal , Adulto , Distribución de Chi-Cuadrado , Cocaína/administración & dosificación , Femenino , Fibrinógeno/metabolismo , Humanos , Lipoproteína(a)/sangre , Masculino , Persona de Mediana Edad , Plasminógeno/metabolismo , Inhibidor 1 de Activador Plasminogénico/sangre , Activador de Tejido Plasminógeno/sangre
20.
Mol Biochem Parasitol ; 73(1-2): 157-64, 1995 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8577323

RESUMEN

Serine proteases play an important role in a diverse array of biological processes, including embryogenesis, metastasis, angiogenesis, thrombolysis and tissue invasion by certain parasites. The latter observation prompted us to explore the possibility that the tissue-invasive ocular parasite Acanthamoeba castellanii elaborates one or more serine proteases. Acanthamoeba sp. are pathogenic free-living amoebae that can produce an invasive, blinding inflammatory disease of the cornea, termed Acanthamoeba keratitis. The present study reports the preliminary purification and characterization of a novel plasminogen activator from an ocular isolate of A. castellanii. The parasite-derived enzyme has a molecular mass of approx. 40 kDa and produces a single band of lysis on fibrinogen-agarose zymographs. Activity of the enzyme is completely inhibited by treatment with diisopropylfluorophosphate, indicating that it is a serine protease. The parasite-derived serine protease is not inhibited by amiloride which is a strong inhibitor of urokinase-type plasminogen activator. Additionally, the enzyme is not inhibited by plasminogen activator inhibitor-1 which is the primary physiological inhibitor of both urokinase and tissue-type plasminogen activator. It does not cross-react with antibodies specific for human urokinase or tissue-type plasminogen activator. The parasite-derived enzyme activates plasminogen from several mammalian species, including human, cow and pig. Thus, it is possible that this parasite-derived serine protease contributes to the pathogenesis of Acanthamoeba keratitis.


Asunto(s)
Acanthamoeba/enzimología , Activadores Plasminogénicos/aislamiento & purificación , Acanthamoeba/aislamiento & purificación , Acanthamoeba/patogenicidad , Queratitis por Acanthamoeba/parasitología , Amilorida/farmacología , Animales , Bovinos , Reacciones Cruzadas , Humanos , Isoflurofato/farmacología , Peso Molecular , Inhibidor 1 de Activador Plasminogénico/farmacología , Activadores Plasminogénicos/inmunología , Activadores Plasminogénicos/metabolismo , Inactivadores Plasminogénicos/farmacología , Inhibidores de Serina Proteinasa/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA